Mitral Valve Disease (MVD): Proposal for an Optimisation of the Left Atrium on Aorta Ratio (LA/AO) - WSAVA2010 - VIN
![Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis | Circulation Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis | Circulation](https://www.ahajournals.org/cms/asset/033a64ea-adf7-4344-a913-ccbf3d1f55a5/14ff3.jpg)
Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis | Circulation
NT-proBNP zur Unterscheidung kardialer und respiratorischer Ursachen für Husten oder Dyspnoe beim Hund
![Addition of N‐terminal pro‐B natriuretic peptide to soluble fms‐like tyrosine kinase‐1/placental growth factor ratio > 38 improves prediction of pre‐eclampsia requiring delivery within 1 week: a longitudinal cohort study - Sabriá - Addition of N‐terminal pro‐B natriuretic peptide to soluble fms‐like tyrosine kinase‐1/placental growth factor ratio > 38 improves prediction of pre‐eclampsia requiring delivery within 1 week: a longitudinal cohort study - Sabriá -](https://obgyn.onlinelibrary.wiley.com/cms/asset/316d9616-2d8a-4675-b3f8-c77d17d07bc6/uog19040-fig-0006-m.jpg)
Addition of N‐terminal pro‐B natriuretic peptide to soluble fms‐like tyrosine kinase‐1/placental growth factor ratio > 38 improves prediction of pre‐eclampsia requiring delivery within 1 week: a longitudinal cohort study - Sabriá -
![Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/240a2846-00ac-43a3-8ba8-b5ef6615d918/ejhf2113-toc-0001-m.jpg)
Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library
![Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b5c669d9-0d0d-40f7-980b-5ac17b4fee7c/ejhf2113-fig-0001-m.jpg)
Use of biomarkers to diagnose and manage cardiac amyloidosis - Castiglione - 2021 - European Journal of Heart Failure - Wiley Online Library
![JCM | Free Full-Text | Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers JCM | Free Full-Text | Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers](https://pub.mdpi-res.com/jcm/jcm-12-00431/article_deploy/html/images/jcm-12-00431-g002.png?1672968231)
JCM | Free Full-Text | Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
![Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis | Circulation Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis | Circulation](https://www.ahajournals.org/cms/asset/0ec5cd79-4dd5-4831-943c-89fafd097f1f/14ff1.jpg)